ClinicalTrials HQ

Guangdong Hengrui Pharmaceutical Co., Ltd

Guangdong Hengrui Pharmaceutical Co., Ltd

Explore linked clinical trials.

31 results · Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of SHR-2173 in Participants With Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingPhase 22026-09-29NCT07299422
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel DiseaseModerate-to-severe Inflammatory Bowel DiseaseRecruitingPhase 12026-09-25NCT07758101
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With ObesityBody Weight ManagementNot yet recruitingPhase 12026-09-17NCT07826364
A Study of SHR-1819 Injection in Adolescents With Severe Atopic DermatitisAdolescents With Moderate-to-severe Atopic DermatitisRecruitingPhase 32026-09-08NCT07309055
A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy AdultsSkin and Connective Tissue Diseases, connective tissue disorder, cutaneous lupus erythematosus, skin disorderRecruitingPhase 12026-08-31NCT07749651
Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderRecruitingPhase 22026-08-20NCT07719530
A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 22026-08-18NCT07640451
A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisHypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitisRecruitingPhase 32026-08-17NCT07688772
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisPlaque PsoriasisNot yet recruitingPhase 22026-08-11NCT07758075
A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic AsthmaAsthma With Eosinophilic PhenotypeActive, not recruitingPhase 32026-08-10NCT06653322
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPDChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 12026-07-20NCT07567872
A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy ParticipantsAsthma With Eosinophilic PhenotypeNot yet recruitingPhase 12026-07-14NCT07701239
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic DermatitisModerate-to-severe Atopic DermatitisActive, not recruitingPhase 22026-06-04NCT07321951
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative ColitisAdult Patients With Moderately to Severely Active Ulcerative ColitisActive, not recruitingPhase 22026-06-04NCT07232576
A Phase II Study of SHR-2173 Injection in Patients With Myasthenia GravisNeoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeNot yet recruitingPhase 22026-06-03NCT07622342
Phase I Study of SHR-2173 Injection in Patients With Primary Immune ThrombocytopeniaCytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathyRecruitingPhase 12026-05-28NCT07206758
A Study of SHR-2173 in Participants With Primary IgA NephropathyFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorderRecruitingPhase 22026-05-13NCT07354932
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid ArthritisModerate to Severe Active Rheumatoid ArthritisActive, not recruitingPhase 22026-05-01NCT07233655
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularisprurigo nodularisRecruitingPhase 2 / Phase 32026-04-29NCT06554509
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic DermatitisModerate-to-severe Atopic DermatitisRecruitingPhase 22026-04-08NCT07211542
A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma GangrenosumSkin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular diseaseNot yet recruitingPhase 22026-03-03NCT07444684
A Phase I Study of SHR-4712 in Patients With Advanced Solid TumorsAdvanced Solid TumorActive, not recruitingPhase 12026-01-28NCT06993116
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous NephropathyPrimary Membranous NephropathyRecruitingPhase 22026-01-26NCT07289763
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary FibrosisIPF and PPFRecruitingPhase 22025-12-24NCT07192939
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma PatientsEosinophilic Asthma PatientsRecruitingPhase 22025-12-18NCT06441812